CN110872329A - Iridium complex and preparation method and application thereof - Google Patents

Iridium complex and preparation method and application thereof Download PDF

Info

Publication number
CN110872329A
CN110872329A CN201911060346.XA CN201911060346A CN110872329A CN 110872329 A CN110872329 A CN 110872329A CN 201911060346 A CN201911060346 A CN 201911060346A CN 110872329 A CN110872329 A CN 110872329A
Authority
CN
China
Prior art keywords
derivatives
iridium complex
iridium
derivative
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201911060346.XA
Other languages
Chinese (zh)
Inventor
杨楚罗
陆光照
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shenzhen University
Original Assignee
Shenzhen University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenzhen University filed Critical Shenzhen University
Priority to CN201911060346.XA priority Critical patent/CN110872329A/en
Publication of CN110872329A publication Critical patent/CN110872329A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0033Iridium compounds
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/30Coordination compounds
    • H10K85/341Transition metal complexes, e.g. Ru(II)polypyridine complexes
    • H10K85/342Transition metal complexes, e.g. Ru(II)polypyridine complexes comprising iridium
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1007Non-condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1011Condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • C09K2211/1033Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom with oxygen
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1044Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1044Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
    • C09K2211/1048Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms with oxygen
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1074Heterocyclic compounds characterised by ligands containing more than three nitrogen atoms as heteroatoms
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/18Metal complexes
    • C09K2211/185Metal complexes of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Electroluminescent Light Sources (AREA)

Abstract

The invention discloses an iridium complex and a preparation method and application thereof. The iridium complex has the following structure:
Figure DDA0002257762680000011
wherein the C-segment coordinating group is selected from: phenyl, pyridyl, thienyl, pyrimidinyl; the N-segment coordinating group is selected from: pyridyl, pyrimidinyl, pyridazinyl, triazinyl, thiazolyl, imidazolyl, quinolinyl, isoquinolinyl, quinazolinyl, or pteridinyl; r1Selected from: alkane derivatives, ether derivatives, halogenated hydrocarbon derivatives, ketone derivatives, benzene derivatives, pyridine derivatives, naphthalene derivatives; r2Selected from: alcohol derivatives, amine derivatives, benzene derivatives, pyridine derivatives, pyrimidine derivatives, diphenylamine derivatives, carbazole derivatives, carboAn quinoline derivative, a 9, 10-dihydroacridine derivative, a phenoxazine derivative, a phenothiazine derivative and an azole derivative. The iridium complex has the characteristics of high carrier transport capacity, simple synthesis, stable chemical property and easy sublimation and purification.

Description

Iridium complex and preparation method and application thereof
Technical Field
The invention relates to the technical field of luminescent devices, in particular to an iridium complex and a preparation method and application thereof.
Background
Under the large background of increasing global energy demand and great ecological environment worries, governments of various countries continuously and vigorously develop sustainable energy-saving technologies and industries based on high technology. An Organic Light-emitting Diode (OLED), also called an Organic Light-emitting Diode, is a device for converting electric energy into Light energy by applying a voltage thereto. Since the Duncuo cloud of Kodak corporation published the OLED with low voltage starting, high efficiency and high brightness, small molecule organic thin film double-layer structure in 1987, the research of electroluminescent materials and devices has attracted great interest in the world science and technology field and the industry. The OLEDs are flat panel display technologies with low power consumption, wide viewing angle, large area, and soft screen implementation, and are widely considered to be capable of replacing displays such as liquid crystal LCDs and inorganic LEDs, and can be used for ideal display screens of mobile phones and color tvs, and show attractive prospects in solid state lighting and flat panel display.
The OLED device mainly comprises a transparent anode, a hole transport layer, a light emitting layer, an electron transport layer and a cathode. Wherein the properties of the light emitting material in the light emitting layer are of critical importance. In a metal complex luminescent system, electrons and holes are compounded to generate excitons, the ratio of singlet excitons to triplet excitons is 1:3, the singlet excitons are converted into the triplet excitons through intersystem crossing due to a heavy atom effect, and finally phosphorescence is emitted by radiation, so that the quantum efficiency can reach 100%. The phosphorescent iridium Ir (III) complex is the most potential OLED luminescent material due to the advantages of good thermal stability, short excited state life, easy adjustment of luminescent color, 100% internal quantum efficiency and the like.
Currently, the commercial green and red materials are iridium complexes. Cost control is crucial in OLED industrialization. The luminescent material, particularly the iridium complex, is key, if the room-temperature, rapid and efficient synthesis of the complex can be realized and the sublimation rate of the complex is improved, the production cost of the material and the device can be greatly reduced, and the method is very key for promoting the industrialization process of the material and the device. In addition, a quaternary ring structure generated by the auxiliary ligand and the iridium atom is not reported. A more serious problem commonly exists in the current devices: the hole mobility of the hole layer is much greater than the electron mobility of the electron layer, which can lead to carrier imbalance and reduced device efficiency. Therefore, if the developed iridium complex luminescent material has good carrier transmission capability, the carrier transmission can be balanced, the carrier composite region can be widened, the device efficiency can be improved, and the iridium complex luminescent material has important research significance for improving the performance of the device. In addition, the ease of synthesis, synthesis yield, and sublimation purification yield of the complex for practical materials are critical to reduce the manufacturing costs of materials and devices. Therefore, it is an urgent problem to provide a novel iridium complex luminescent material with simple synthesis, good carrier transport capability, and high synthesis and sublimation yield.
Accordingly, the prior art is yet to be improved and developed.
Disclosure of Invention
In view of the defects of the prior art, the invention aims to provide an iridium complex, and a preparation method and application thereof, and aims to solve the problem that the existing luminescent material has poor carrier transport capability.
The specific technical scheme of the invention is as follows:
an iridium complex, wherein the iridium complex has a structure as shown below:
Figure BDA0002257762660000021
wherein the C-segment coordinating group is selected from: phenyl, pyridyl, thienyl, pyrimidinyl;
the N-segment coordinating group is selected from: pyridyl, pyrimidinyl, pyridazinyl, triazinyl, thiazolyl, imidazolyl, quinolinyl, isoquinolinyl, quinazolinyl, pteridinyl;
R1selected from: alkane derivatives, ether derivatives, halogenated hydrocarbon derivatives, ketone derivatives, benzene derivatives, pyridine derivatives, naphthalene derivatives;
R2selected from: alcohol derivatives, amine derivatives, benzene derivatives, pyridine derivatives, pyrimidine derivatives, diphenylamine derivatives, carbazole derivatives, carboline derivatives, 9, 10-dihydroacridine derivatives, phenoxazine derivatives, phenothiazine derivatives, and azole derivatives.
The iridium complex, whereinR is1Selected from: alkane derivatives, ether derivatives, halogenated hydrocarbon derivatives, ketone derivatives, benzene derivatives, pyridine derivatives and naphthalene derivatives which are respectively substituted by one or more of C1-C6 alkyl, C1-C6 alkoxy, C1-C6 halogenated hydrocarbon groups and halogen elements;
the R is2Selected from: alcohol derivatives, amine derivatives, benzene derivatives, pyridine derivatives, pyrimidine derivatives, diphenylamine derivatives, carbazole derivatives, carboline derivatives, 9, 10-dihydroacridine derivatives, phenoxazine derivatives, phenothiazine derivatives and azole derivatives, which are respectively substituted by one or more of C1-C6 alkyl, C1-C6 alkoxy, C1-C6 halogenated hydrocarbon groups and halogen elements.
The iridium complex, wherein R is1Selected from:
Figure BDA0002257762660000022
Figure BDA0002257762660000023
Figure BDA0002257762660000031
the R is2Selected from:
Figure BDA0002257762660000032
Figure BDA0002257762660000033
the iridium complex, wherein the C-segment coordinating group is selected from: phenyl, pyridyl, thienyl and pyrimidyl which are respectively substituted by one or more of C1-C6 alkyl, C1-C6 alkoxy, C1-C6 halogenated hydrocarbon, halogen elements, cyano, aniline, carbazole and oxadiazole.
The iridium complex, wherein the C-segment coordinating group is selected from:
Figure BDA0002257762660000034
Figure BDA0002257762660000035
the iridium complex, wherein the N-segment coordinating group is selected from: pyridyl, pyrimidyl, pyridazinyl, triazinyl, thiazolyl, imidazolyl, quinolyl, isoquinolyl, quinazolinyl or pteridinyl substituted by one or more of C1-C6 alkyl, C1-C6 alkoxy, C1-C6 halogenated hydrocarbon group and halogen elements respectively.
The iridium complex, wherein the N-segment coordinating group is selected from:
Figure BDA0002257762660000036
Figure BDA0002257762660000041
the iridium complex, wherein the iridium complex is selected from the group consisting of:
Figure BDA0002257762660000042
Figure BDA0002257762660000051
Figure BDA0002257762660000061
Figure BDA0002257762660000071
Figure BDA0002257762660000081
Figure BDA0002257762660000091
a method for preparing the iridium complex, which comprises the following steps:
providing thioamide derivatives, main ligands containing nitrogen heterocycles, and iridium halides;
mixing the main ligand of the nitrogen-containing heterocycle with the iridium halide to obtain a halogen complex of iridium;
and mixing the iridium halogen complex with the thioamide derivative to obtain the iridium complex.
Use of an iridium complex as described above in the preparation of a light-emitting device.
Has the advantages that: the iridium complex has the characteristics of easy synthesis, good carrier transmission capability, stable chemical property, easy sublimation and purification and higher synthesis yield. Because the iridium complex contains nitrogen heterocycle, carbon-sulfur double bond, carbon-nitrogen double bond and other functional groups, the N-segment coordinated group, the C-segment coordinated group and R1、R2Specific substituent groups such as diphenylamine, carbazole and the like can be introduced, so that the comprehensive photoelectric property of the iridium complex can be effectively regulated and controlled, and convenience is provided for obtaining a high-efficiency organic electroluminescent device and application of the device in the fields of illumination and display.
Drawings
FIG. 1 is an electroluminescence spectrum of an iridium complex Samc 8 used in an organic electroluminescent device.
Fig. 2 is a graph of current density and luminance versus voltage for an organic electroluminescent device using the iridium complex Samc 8 according to the present invention.
Fig. 3 is a graph of the current efficiency and luminance of the iridium complex Samc 8 for an organic electroluminescent device provided by the present invention.
Detailed Description
The invention provides an iridium complex and a preparation method and application thereof, and the invention is further described in detail below in order to make the purpose, technical scheme and effect of the invention clearer and more clear. It should be understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention. Terms used in the present invention generally have meanings commonly understood by those of ordinary skill in the art, unless otherwise specified.
The invention provides an iridium complex, wherein the iridium complex has a structure shown as follows:
Figure BDA0002257762660000101
wherein the C-block coordinating group is selected from: phenyl, pyridyl, thienyl, pyrimidinyl;
the N-segment coordinating group is selected from: pyridyl, pyrimidinyl, pyridazinyl, triazinyl, thiazolyl, imidazolyl, quinolinyl, isoquinolinyl, quinazolinyl, pteridinyl;
R1selected from: alkane derivatives, ether derivatives, halogenated hydrocarbon derivatives, ketone derivatives, benzene derivatives, pyridine derivatives, naphthalene derivatives;
R2selected from: alcohol derivatives, amine derivatives, benzene derivatives, pyridine derivatives, pyrimidine derivatives, diphenylamine derivatives, carbazole derivatives, carboline derivatives, 9, 10-dihydroacridine derivatives, phenoxazine derivatives, phenothiazine derivatives, and azole derivatives.
The invention provides a novel iridium complex containing a nitrogen heterocyclic main ligand and a thioamide derivative auxiliary ligand. The iridium complex comprises nitrogen heterocyclic rings, carbon-sulfur double bonds, carbon-nitrogen double bonds and other functional groups, and meanwhile, the N-segment coordinated group, the C-segment coordinated group and the R1、R2All can introduce specific substituent groups, such as diphenylamine, carbazole and other groups, and can effectively improve the carrier transmission capability of the complex. Moreover, because the radius of the sulfur atom S is larger than that of oxygen, the sulfur atom S is easy to deform, and the electron donating capability of the nitrogen atom N is strong, the coordination capability of the sulfur and nitrogen atoms and the iridium atom is strong, so that the complex-forming reaction is easy to occur, the complex can be obtained by stirring at room temperature, and meanwhile, the complex synthesis and sublimation yield are also obviously improved.
In the structural formula of the iridium complex, the thioamide derivative is an auxiliary ligand of the iridium complex, and the auxiliary ligand comprises R1、R2Two radicals, R1Represents an alkane derivative, an ether derivative, a halogenated hydrocarbon derivative,Ketone derivatives, benzene derivatives, pyridine derivatives, naphthalene derivatives, and the like; r2Represents an alcohol derivative, an amine derivative, a benzene derivative, a pyridine derivative, a pyrimidine derivative, a diphenylamine derivative, a carbazole derivative, a carboline derivative, a 9, 10-dihydroacridine derivative, a phenoxazine derivative, a phenothiazine derivative, an azole derivative, or the like. In addition, R is1、R2Both groups may be substituted or unsubstituted, for example the alkane derivative may be a substituted or unsubstituted alkane derivative, or the alkane derivative includes both substituted and unsubstituted alkane derivatives. The substituted group refers to a group containing a substituent group, and the substituent group can be one or more of C1-C6 alkyl, C1-C6 alkoxy, C1-C6 halogenated hydrocarbon, halogen elements, cyano, aniline, carbazole and oxadiazole. That is, the R1Selected from: alkane derivatives, ether derivatives, halogenated hydrocarbon derivatives, ketone derivatives, benzene derivatives, pyridine derivatives and naphthalene derivatives which are respectively substituted by one or more of C1-C6 alkyl, C1-C6 alkoxy, C1-C6 halogenated hydrocarbon groups and halogen elements; the R is2Selected from: alcohol derivatives, amine derivatives, benzene derivatives, pyridine derivatives, pyrimidine derivatives, diphenylamine derivatives, carbazole derivatives, carboline derivatives, 9, 10-dihydroacridine derivatives, phenoxazine derivatives, phenothiazine derivatives and azole derivatives, which are respectively substituted by one or more of C1-C6 alkyl, C1-C6 alkoxy, C1-C6 halogenated hydrocarbon groups and halogen elements. Further, "C1-C6" means that the number of carbon atoms in the substituent is 1 to 6.
Specifically, the R is1Selected from:
Figure BDA0002257762660000111
Figure BDA0002257762660000112
the R is2Selected from:
Figure BDA0002257762660000113
Figure BDA0002257762660000114
in the structural formula of the iridium complex of the invention,
Figure BDA0002257762660000115
the nitrogen heterocyclic main ligand of the iridium complex comprises a C-section coordinated group and an N-section coordinated group. The C-segment coordinating group is selected from: phenyl, pyridyl, thienyl, pyrimidinyl; the N-segment coordinating group is selected from: pyridyl, pyrimidinyl, pyridazinyl, triazinyl, thiazolyl, imidazolyl, quinolinyl, isoquinolinyl, quinazolinyl, or pteridinyl. It is noted that the phenyl group may be a substituted or substituted phenyl group, i.e. the phenyl group includes a substituted or substituted phenyl group, and similarly the pyridyl, thienyl, pyrimidinyl, pyridazinyl, triazinyl, thiazolyl, imidazolyl, quinolinyl, isoquinolinyl, quinazolinyl, or pteridinyl groups may each be substituted or unsubstituted. The substituted group refers to a group containing a substituent group, and the substituent group can be one or more of C1-C6 alkyl, C1-C6 alkoxy, C1-C6 halogenated hydrocarbon, halogen elements, cyano, aniline, carbazole and oxadiazole. That is, the C-block coordinating group is selected from: phenyl, pyridyl, thienyl and pyrimidyl which are respectively substituted by one or more of C1-C6 alkyl, C1-C6 alkoxy, C1-C6 halogenated hydrocarbon, halogen elements, cyano, aniline, carbazole and oxadiazole. The N-segment coordinating group is selected from: pyridyl, pyrimidyl, pyridazinyl, triazinyl, thiazolyl, imidazolyl, quinolyl, isoquinolyl, quinazolinyl or pteridinyl substituted by one or more of C1-C6 alkyl, C1-C6 alkoxy, C1-C6 halogenated hydrocarbon group and halogen elements respectively.
Specifically, the group coordinated by the C segment of the iridium complex is selected from:
Figure BDA0002257762660000121
Figure BDA0002257762660000122
specifically, the iridium complex, the N-segment coordinating group is selected from:
Figure BDA0002257762660000123
Figure BDA0002257762660000124
more specifically, the iridium complex has the following chemical structural formula:
Figure BDA0002257762660000131
Figure BDA0002257762660000141
Figure BDA0002257762660000151
Figure BDA0002257762660000161
Figure BDA0002257762660000171
the nitrogen heterocyclic ring, carbon-sulfur double bond, carbon-nitrogen double bond and other groups in the iridium complex molecule are good electron transmission groups, and a hole transmission group such as diphenylamine, carbazole and the like is introduced into thioamide, so that the luminescent material with bipolar property can be synthesized, and the photophysical properties of the luminescent material can be adjusted and controlled, thereby balancing the injection and transmission of holes and electrons, widening the recombination region of current carriers, improving the efficiency of devices and reducing the efficiency roll-off. For example, the device prepared by taking the iridium complex Samc 8 as a luminescence center in the invention has good device performance. And because the radius of the sulfur atom is larger than that of oxygen, the deformability is large, the electron-donating capability of the nitrogen atom is strong, the combination of the sulfur atom and the transition metal iridium is firmer, and the synthesis yield and the vacuum sublimation yield are higher. The synthesis yield of the iridium complex is generally higher than 80%, the vacuum sublimation rate is also higher than 70%, and the synthesis yield is far higher than that (< 70%) and vacuum sublimation rate (< 60%) of most iridium complexes at present, so that the iridium complex is very suitable for industrial production.
Further, the present invention also provides a preparation method of the iridium complex, wherein the preparation method comprises:
providing thioamide derivatives, main ligands containing nitrogen heterocycles, and iridium halides;
mixing the main ligand of the nitrogen-containing heterocycle with the iridium halide to obtain a halogen complex of iridium;
and mixing the iridium halogen complex with the thioamide derivative to obtain the iridium complex.
Specifically, the thioamide derivative of the present invention can be purchased commercially or prepared by the following method: will contain R1Isothiocyanate (R) substituted with substituent1The group definition is as described above), and the same substituted or non-substituted benzene, pyridine, pyrimidine, diphenylamine, bipyridine amine, carbazole, carboline, 9, 10-dihydro acridine, phenoxazine, phenothiazine, azole and the like react for two hours at low temperature in anhydrous THF under the action of n-butyl lithium and under the anaerobic condition to obtain the corresponding lithium salt THF solution of thioacetamide.
The iridium complexes according to the invention can be prepared, for example, by reacting the primary ligand with IrCl3Refluxing in an ethoxyethanol solution for 10 hours in a ratio of 2:1, cooling, adding water to separate out, and filtering to obtain an iridium chloro-bridged complex; then stirring the iridium complex with thioamide derivatives with twice equivalent weight for one hour at room temperature to obtain crude products of the iridium complex, carrying out column chromatography to obtain pure products, and further carrying out sublimation purification under the vacuum condition to obtain the luminescent material meeting the requirements of the preparation device.
The iridium complex has the advantages of simple preparation method, room-temperature reaction for dozens of minutes and high synthesis yield.
A light-emitting device, wherein the light-emitting device comprises the iridium complex as described above.
The invention also provides an application of the iridium complex in preparation of a light-emitting device. Wherein the light emitting device may be an organic electroluminescent device.
The iridium complex can be used for preparing an organic electroluminescent device, for example, the organic electroluminescent device comprises a substrate, an anode, a hole injection material, a hole transport layer, an organic luminescent layer, an electron transport layer, an electron injection material and a cathode. The substrate is glass, the anode is indium tin oxide, the hole injection layer is 2,3,6,7,10, 11-hexacyano-1, 4,5,8,9, 12-hexaazatriphenylene HAT-CN, the hole layer is made of 4,4' -cyclohexyl bis [ N, N-bis (4-methylphenyl) aniline TAPC material, the electron transport layer is made of 1,3, 5-tris [ (3-pyridyl) -3-phenyl ] benzene TmPyPB, the electron injection material is LiF, and the cathode is metal Al; the organic light-emitting layer comprises a main material and a light-emitting material, wherein the main material is 4,4' -tri (9-carbazolyl) triphenylamine TCTA, and the light-emitting material is the iridium complex.
The present invention is described in further detail below with reference to specific examples and with reference to the data. It will be understood that this example is intended to illustrate the invention and not to limit the scope of the invention in any way. In the following examples, various procedures and methods not described in detail are conventional methods well known in the art.
Example 1
Preparation of lithium salt THF solution of assistant ligand isopropyl dianilino substituted thioamide
Diphenylamine and n-butyl lithium are reacted in THF solution at low temperature to extract hydrogen, and then reacted with isopropyl isothiocyanate to obtain lithium salt THF solution of isopropyl diphenylamine-thioamide
Figure BDA0002257762660000181
Directly used for the next step of complex synthesis reaction.
Other lithium thioamides in THF can be prepared using the above method:
Figure BDA0002257762660000191
example 2 preparation of an Iridium Complex according to the invention
The main ligands 1- (4- (trifluoromethyl) phenyl) isoquinoline and IrCl3Refluxing in an ethoxy ethanol solution for 10 hours in a ratio of 2:1, cooling and filtering to obtain an iridium chloro-bridge complex; then 10mmol (15.43g) of the chloro-bridged complex and 20mmol of lithium salt THF solution of isopropyl-diphenylaminothioamide were stirred in ethylene glycol dimethyl ether solution at room temperature for one hour to obtain crude iridium complex, and column chromatography gave 16.11g of pure Samc 8 (yield: 80%). And further 5g of Samc 8 were placed in a quartz tube at 10-5Heating, sublimating and purifying under the Pa vacuum condition to obtain 3.5g of luminescent material (sublimation rate is 70%) meeting the requirements of preparing devices. The reaction is shown below:
Figure BDA0002257762660000201
the obtained iridium complex Samc 8 is analyzed by nuclear magnetic resonance hydrogen spectrum and high-resolution mass spectrum as follows:
1H NMR(400MHz,CDCl3)δ10.01(d,J=6.42Hz,1H),8.95-8.74(m,3H),8.33-7.97(m,4H),7.90-7.71(m,6H),7.33(t,J=7.82Hz,4H),7.21(d,J=7.52Hz,4H),7.14(t,J=7.39Hz,3H),7.06-7.01(m,1H),6.67(s,1H),6.27(s,1H),4.05(dt,J=12.73,6.33Hz,1H),0.50(d,J=6.34Hz,3H),-0.07(d,J=6.39Hz,3H).
HRMS(ESI)m/z calcd for C48H36F6IrN4S[M+H]:1007.2188,found:1007.2184.
with reference to the above method, different primary ligands are selected:
Figure BDA0002257762660000202
Figure BDA0002257762660000203
Figure BDA0002257762660000211
Figure BDA0002257762660000212
with the lithium salt of thioamide prepared in example 1 in THF gave the following compound:
Figure BDA0002257762660000213
Figure BDA0002257762660000221
Figure BDA0002257762660000231
Figure BDA0002257762660000241
Figure BDA0002257762660000251
Figure BDA0002257762660000261
example 3 preparation of Iridium Complex Samc 8 organic electroluminescent device
The following description will be made of the preparation of the organic electroluminescent device of the present invention, taking Samc 8 as an example of the preparation of the organic electroluminescent device as the luminescent center of the luminescent layer. The structure of the OLEDs device includes: a substrate, an anode, a hole injection material, a hole transport layer, an organic light emitting layer, an electron transport layer, an electron injection material, and a cathode. The substrate is glass, the anode is indium tin oxide, the hole injection layer is 2,3,6,7,10, 11-hexacyano-1, 4,5,8,9, 12-hexaazatriphenylene HAT-CN (5nm), and the evaporation rate is 0.05 nm/s; the hole layer adopts 4,4' -cyclohexyl di [ N, N-di (4-methylphenyl) aniline TAPC material (55nm), and the evaporation rate is 0.05 nm/s; the electron transport layer adopts 1,3, 5-tri [ (3-pyridyl) -3-phenyl ] benzene TmPyPB (55nm), and the evaporation rate is 0.05 nm/s; the electron injection material is LiF (1nm), and the evaporation rate is 0.01 nm/s; the cathode is metal Al (100nm), and the evaporation rate is 0.2 nm/s; the organic light-emitting layer is of a doped structure, the thickness of the organic light-emitting layer is 20nm, the organic light-emitting layer comprises a main material and a light-emitting material, the main material is 4,4' -tris (9-carbazolyl) triphenylamine TCTA, the light-emitting material is an iridium complex, and the mass fraction of the iridium complex is 8 wt%.
Several materials used in the present invention have the following structure:
Figure BDA0002257762660000262
the invention selects a new iridium complex Samc 8 as a luminescence center to prepare an organic electroluminescent device. Referring to fig. 1, fig. 2 and fig. 3 together, fig. 1 is an electroluminescence spectrum of Samc 8 provided by the present invention for an organic electroluminescent device, and fig. 2 and fig. 3 are graphs of photoelectric properties of Samc 8 provided by the present invention for an organic electroluminescent device. As shown in FIGS. 2 and 3, the organic electroluminescent device had a starting voltage of 3.6V and a maximum current efficiency of 10.5cd/A at 1000cd/m2The current efficiency can still be maintained at 8.6cd/a at luminance, showing a very small efficiency roll-off. Research on photophysical properties shows that the iridium complex luminescent material containing the nitrogen heterocyclic main ligand and the thioamide derivative auxiliary ligand has high device efficiency and has practical application value in the fields of display, illumination and the like.
The iridium complex Samc 1-7 and Samc 9-136 prepared in embodiment 2 of the invention can be prepared into an organic electroluminescent device by adopting the method, and has photoelectric properties similar to or superior to those of Samc 8.
The iridium complex provided by the invention can be used as a luminescent material to be applied to a luminescent layer of OLEDs, and the purpose of regulating and controlling the efficiency of a device is achieved by designing and optimizing the structure of a compound.
The iridium complex is a novel iridium complex containing a quaternary ring structure and taking nitrogen heterocycles as main ligands and thioamide derivatives as auxiliary ligands. Nitrogen heterocycle, carbon sulfur, carbon nitrogen, diphenylamine, carbazole and other groups in the iridium complex molecule are beneficial to improving the carrier transmission capability of the material and regulating and controlling the photophysical properties of the luminescent material, so that the injection and transmission of holes and electrons are balanced, the composite region of the carriers is widened, the device efficiency is improved, and the efficiency roll-off is reduced. The iridium complex has the advantages of novel structure, simple synthesis, stable chemical property, easy sublimation and purification, and excellent device performance, and provides convenience for obtaining an efficient organic electroluminescent device and application thereof in the fields of illumination and display.
While the foregoing is directed to embodiments of the present invention, it will be understood by those skilled in the art that various changes may be made without departing from the spirit and scope of the invention.

Claims (10)

1. An iridium complex, characterized in that the iridium complex has the structure shown below:
Figure FDA0002257762650000011
wherein the C-segment coordinating group is selected from: phenyl, pyridyl, thienyl, pyrimidinyl;
the N-segment coordinating group is selected from: pyridyl, pyrimidinyl, pyridazinyl, triazinyl, thiazolyl, imidazolyl, quinolinyl, isoquinolinyl, quinazolinyl, pteridinyl;
R1selected from: alkane derivatives, ether derivatives, halogenated hydrocarbon derivatives, ketone derivatives, benzene derivatives, pyridine derivatives, naphthalene derivatives;
R2selected from: alcohol derivatives, amine derivatives, benzene derivatives, pyridine derivatives, pyrimidine derivatives, diphenylamine derivatives, carbazole derivatives, carboline derivatives, 9, 10-dihydroacridine derivatives, phenoxazine derivatives, phenothiazine derivatives, and azole derivatives.
2. The iridium complex according to claim 1, wherein R is1Selected from: respectively substituted by one or more of C1-C6 alkyl, C1-C6 alkoxy, C1-C6 halogenated hydrocarbon group and halogen element, ether derivative, halogenated hydrocarbon derivative, ketone derivative, benzene derivative, pyridine derivative and naphthalene derivativeAn organism;
the R is2Selected from: alcohol derivatives, amine derivatives, benzene derivatives, pyridine derivatives, pyrimidine derivatives, diphenylamine derivatives, carbazole derivatives, carboline derivatives, 9, 10-dihydroacridine derivatives, phenoxazine derivatives, phenothiazine derivatives and azole derivatives, which are respectively substituted by one or more of C1-C6 alkyl, C1-C6 alkoxy, C1-C6 halogenated hydrocarbon groups and halogen elements.
3. The iridium complex according to claim 1, wherein R is1Selected from:
Figure FDA0002257762650000012
Figure FDA0002257762650000013
the R is2Selected from:
Figure FDA0002257762650000021
Figure FDA0002257762650000022
4. the iridium complex according to claim 1, wherein the group coordinated by the C segment is selected from: phenyl, pyridyl, thienyl and pyrimidyl which are respectively substituted by one or more of C1-C6 alkyl, C1-C6 alkoxy, C1-C6 halogenated hydrocarbon, halogen elements, cyano, aniline, carbazole and oxadiazole.
5. The iridium complex according to claim 1, wherein the group coordinated by the C segment is selected from:
Figure FDA0002257762650000023
Figure FDA0002257762650000024
6. the iridium complex according to claim 1, wherein the N-block coordinating group is selected from: pyridyl, pyrimidyl, pyridazinyl, triazinyl, thiazolyl, imidazolyl, quinolyl, isoquinolyl, quinazolinyl or pteridinyl substituted by one or more of C1-C6 alkyl, C1-C6 alkoxy, C1-C6 halogenated hydrocarbon group and halogen elements respectively.
7. The iridium complex according to claim 1, wherein the N-block coordinating group is selected from:
Figure FDA0002257762650000025
Figure FDA0002257762650000026
8. the iridium complex according to claim 1, wherein the iridium complex is selected from the group consisting of:
Figure FDA0002257762650000031
Figure FDA0002257762650000041
Figure FDA0002257762650000051
Figure FDA0002257762650000061
Figure FDA0002257762650000071
9. a method for producing the iridium complex according to claim 1, comprising:
providing thioamide derivatives, main ligands containing nitrogen heterocycles, and iridium halides;
mixing the main ligand of the nitrogen-containing heterocycle with the iridium halide to obtain a halogen complex of iridium;
and mixing the iridium halogen complex with the thioamide derivative to obtain the iridium complex.
10. Use of an iridium complex as claimed in any one of claims 1 to 8 in the manufacture of a light-emitting device.
CN201911060346.XA 2019-11-01 2019-11-01 Iridium complex and preparation method and application thereof Pending CN110872329A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911060346.XA CN110872329A (en) 2019-11-01 2019-11-01 Iridium complex and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911060346.XA CN110872329A (en) 2019-11-01 2019-11-01 Iridium complex and preparation method and application thereof

Publications (1)

Publication Number Publication Date
CN110872329A true CN110872329A (en) 2020-03-10

Family

ID=69717898

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911060346.XA Pending CN110872329A (en) 2019-11-01 2019-11-01 Iridium complex and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN110872329A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022137033A1 (en) * 2020-12-25 2022-06-30 株式会社半導体エネルギー研究所 Organic metal complex, light-emitting device, light-emitting apparatus, electronic equipment, and illumination apparatus

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006131561A (en) * 2004-11-08 2006-05-25 Idemitsu Kosan Co Ltd Metal complex compound
CN101182412A (en) * 2007-12-18 2008-05-21 江南大学 Amides Ir organometallic complex electroluminescent material and uses thereof
CN101280186A (en) * 2008-05-16 2008-10-08 江南大学 Photophosphorescence material contain iridium complex of phenylquinoline and acidamide group and preparation thereof
CN103045233A (en) * 2012-12-24 2013-04-17 江南大学 Amido organometallic iridium complex luminescent material and preparation method thereof
CN108358971A (en) * 2018-01-31 2018-08-03 马鞍山南京大学高新技术研究院 Complex of iridium of a kind of bamic acid class compound as assistant ligand

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006131561A (en) * 2004-11-08 2006-05-25 Idemitsu Kosan Co Ltd Metal complex compound
CN101182412A (en) * 2007-12-18 2008-05-21 江南大学 Amides Ir organometallic complex electroluminescent material and uses thereof
CN101280186A (en) * 2008-05-16 2008-10-08 江南大学 Photophosphorescence material contain iridium complex of phenylquinoline and acidamide group and preparation thereof
CN103045233A (en) * 2012-12-24 2013-04-17 江南大学 Amido organometallic iridium complex luminescent material and preparation method thereof
CN108358971A (en) * 2018-01-31 2018-08-03 马鞍山南京大学高新技术研究院 Complex of iridium of a kind of bamic acid class compound as assistant ligand

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022137033A1 (en) * 2020-12-25 2022-06-30 株式会社半導体エネルギー研究所 Organic metal complex, light-emitting device, light-emitting apparatus, electronic equipment, and illumination apparatus

Similar Documents

Publication Publication Date Title
KR100966886B1 (en) Novel organic electroluminescent compounds and organic electroluminescent device using the same
KR100933226B1 (en) Novel red phosphorescent compound and organic light emitting device employing it as light emitting material
KR100933229B1 (en) Novel red phosphorescent compound and organic light emitting device employing it as light emitting material
KR100933225B1 (en) Novel Phosphorescent Compound and Organic Light Emitting Device Employing It as Light Emitting Material
KR100910153B1 (en) Novel red electroluminescent compounds and organic electroluminescent device using the same
CN108358971B (en) Iridium complex with thiocarboxylic acid compounds as auxiliary ligands
KR102366721B1 (en) Compound for organic electronic element, organic electronic element comprising the same, and electronic device thereof
KR100966885B1 (en) Novel organic electroluminescent compounds and organic electroluminescent device using the same
CN108484680B (en) Iridium complex with bis-thio aromatic ring/aromatic heterocyclic phosphoric acid compound as auxiliary ligand
KR100923571B1 (en) Novel red electroluminescent compounds and organic electroluminescent device using the same
KR100923655B1 (en) Novel red electroluminescent compounds and organic electroluminescent device using the same
CN108484679B (en) Iridium complex with thio-bis-diaryl/aryl-hetero-phosphoryl imine as auxiliary ligand
WO2013187896A1 (en) Biscarbazole derivative host materials and green emitter for oled emissive region
CN108484678B (en) Iridium complex with thio-aromatic ring/aromatic heterocyclic phosphoric acid compound as auxiliary ligand
KR100933228B1 (en) Novel red phosphorescent compound and organic light emitting device employing it as light emitting material
CN106046060A (en) Iridium complex and preparation method thereof as well as electroluminescent device applying iridium complex
KR102574915B1 (en) Compound for organic electronic element, organic electronic element comprising the same, and electronic device thereof
KR20190086895A (en) Compound for organic electronic element, organic electronic element comprising the same, and electronic device thereof
CN110872329A (en) Iridium complex and preparation method and application thereof
CN106632492A (en) Platinum complex
KR102402033B1 (en) Compound for organic electronic element, organic electronic element comprising the same, and electronic device thereof
CN114524832A (en) Blue light emitting material, organic electroluminescent device and display device
KR20190079975A (en) Compound for organic electronic element, organic electronic element comprising the same, and electronic device thereof
CN106432346A (en) Iridium complex, preparation method thereof and electroluminescent device applying same
KR20140086501A (en) Phosphorescent compound and Organic electroluminescent device using the same

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20200310